Browsing by Author "Martínez Gutiérrez, Javiera"
Now showing 1 - 19 of 19
Results Per Page
Sort Options
- ItemAn RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial(2021) Milton, Shakira; McIntosh, Jennifer; Macrae, Finlay; Chondros, Patty; Trevena, Lyndal; Jenkins, Mark; Walter, Fiona M.; Taylor, Natalie; Boyd, Lucy; Martínez Gutiérrez, JavieraAbstract Background Australian guidelines recommend that all people aged 50–70 years old actively consider taking daily low-dose aspirin (100–300 mg per day) for 2.5 to 5 years to reduce their risk of colorectal cancer (CRC). Despite the change of national CRC prevention guidelines, there has been no active implementation of the guidelines into clinical practice. We aim to test the efficacy of a health consultation and decision aid, using a novel expected frequency tree (EFT) to present the benefits and harms of low dose aspirin prior to a general practice consultation with patients aged 50–70 years, on informed decision-making and uptake of aspirin. Methods Approximately five to seven general practices in Victoria, Australia, will be recruited to participate. Patients 50–70 years old, attending an appointment with their general practitioner (GP) for any reason, will be invited to participate in the trial. Two hundred fifty-eight eligible participants will be randomly allocated 1:1 to intervention or active control arms using a computer-generated allocation sequence stratified by general practice, sex, and mode of trial delivery (face-to-face or teletrial). There are two co-primary outcomes: informed decision-making at 1-month post randomisation, measured by the Multi-dimensional Measure of Informed Choice (MMIC), and self-reported daily use of aspirin at 6 months. Secondary outcomes include decisional conflict at 1-month and other behavioural changes to reduce CRC risk at both time points. Discussion This trial will test the efficacy of novel methods for implementing national guidelines to support informed decision-making about taking aspirin in 50–70-year-olds to reduce the risk of CRC and other chronic diseases. Trial registration The Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620001003965 . Registered on 10 October 2020.
- ItemCancer Screening at a Federally Qualified Health Center : A Qualitative Study on Organizational Challenges in the Era of the Patient-Centered Medical Home(2013) Martínez Gutiérrez, Javiera; Jhingan, Esther; Angulo, Antoinette; Jiménez, Ricardo; Thompson, Beti; Coronado, Gloria D.
- ItemCervical cancer screening and adherence to follow-up among Hispanic women study protocol : a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women(2012) Duggan, Catherine; Coronado, Gloria; Martínez Gutiérrez, Javiera; Byrd, Theresa L.; Carosso, Elizabeth; López, Cathy; Benavides, María; Thompson, BetiAbstract Background In the US, Hispanic women have a higher incidence of, and mortality from, cervical cancer than non-Hispanic white women. The reason for this disparity may be attributable to both low rates of screening and poor adherence to recommended diagnostic follow-up after an abnormal Pap test. The 'Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women' study is a collaboration between a research institution and community partners made up of members from community based organizations, the Yakima Valley Farm Workers Clinic and the Breast, Cervical, and Colon Health Program of the Yakima District . The study will assess the efficacy of two culturally-appropriate, tailored educational programs designed to increase cervical cancer screening among Hispanic women, based in the Yakima Valley, Washington, US. Methods/design A parallel randomized-controlled trial of 600 Hispanic women aged 21–64, who are non-compliant with Papanicolau (Pap) test screening guidelines. Participants will be randomized using block randomization to (1) a control arm (usual care); (2) a low-intensity information program, consisting of a Spanish-language video that educates women on the importance of cervical cancer screening; or (3) a high-intensity program consisting of the video plus a ‘promotora’ or lay-community health educator-led, home based intervention to encourage cervical cancer screening. Participants who attend cervical cancer screening, and receive a diagnosis of an abnormal Pap test will be assigned to a patient navigator who will provide support and information to promote adherence to follow-up tests, and any necessary surgery or treatment. Primary endpoint: Participants will be tracked via medical record review at community-based clinics, to identify women who have had a Pap test within 7 months of baseline assessment. Medical record reviewers will be blinded to randomization arm. Secondary endpoint: An evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among participants who receive an abnormal Pap test result. An additional secondary endpoint is the cost-effectiveness of the two different intensity intervention programs. Discussion This culturally sensitive intervention aims to increase compliance and adherence to cervical screening in a Hispanic population. If effective, such interventions may reduce incidence of cervical cancer. Trial registration NCT01525433Abstract Background In the US, Hispanic women have a higher incidence of, and mortality from, cervical cancer than non-Hispanic white women. The reason for this disparity may be attributable to both low rates of screening and poor adherence to recommended diagnostic follow-up after an abnormal Pap test. The 'Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women' study is a collaboration between a research institution and community partners made up of members from community based organizations, the Yakima Valley Farm Workers Clinic and the Breast, Cervical, and Colon Health Program of the Yakima District . The study will assess the efficacy of two culturally-appropriate, tailored educational programs designed to increase cervical cancer screening among Hispanic women, based in the Yakima Valley, Washington, US. Methods/design A parallel randomized-controlled trial of 600 Hispanic women aged 21–64, who are non-compliant with Papanicolau (Pap) test screening guidelines. Participants will be randomized using block randomization to (1) a control arm (usual care); (2) a low-intensity information program, consisting of a Spanish-language video that educates women on the importance of cervical cancer screening; or (3) a high-intensity program consisting of the video plus a ‘promotora’ or lay-community health educator-led, home based intervention to encourage cervical cancer screening. Participants who attend cervical cancer screening, and receive a diagnosis of an abnormal Pap test will be assigned to a patient navigator who will provide support and information to promote adherence to follow-up tests, and any necessary surgery or treatment. Primary endpoint: Participants will be tracked via medical record review at community-based clinics, to identify women who have had a Pap test within 7 months of baseline assessment. Medical record reviewers will be blinded to randomization arm. Secondary endpoint: An evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among participants who receive an abnormal Pap test result. An additional secondary endpoint is the cost-effectiveness of the two different intensity intervention programs. Discussion This culturally sensitive intervention aims to increase compliance and adherence to cervical screening in a Hispanic population. If effective, such interventions may reduce incidence of cervical cancer. Trial registration NCT01525433
- ItemDealing with an Abnormal Pap test: Latinas' Views(2015) Martínez Gutiérrez, Javiera; Banegas, M.P.; Coronado, G.D.; Carosso, E.; Gonzalez, N.E.; Rodriguez, V.; Islas, I.; Thompson, B.
- ItemDevelopment of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol : a randomized controlled trial(2017) Martínez Gutiérrez, Javiera; Soto Subiabre, Mauricio Andrés; Capurro, Daniel; Puschel Illanes, Klaus; Momany, McKenzie C.; Ciampi, Francis; Thompson, BetiAbstract Background In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized controlled trials in Latin America assessing its use in cervical cancer screening. The ‘Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile’ study aims to determine the efficacy of a text-message intervention on Pap test adherence among Chilean women in the metropolitan region of Santiago. Methods/design This study is a parallel randomized-controlled trial of 400 Chilean women aged 25–64 who are non-adherent with current recommendations for Pap test screening. Participants will be randomly assigned to (1) a control arm (usual care) or (2) an intervention arm, where text and voice messages containing information and encouragement to undergo screening will be sent to the women. The primary endpoint is completion of a Pap test within 6 months of baseline assessment, as determined by medical record review at community-based clinics. Medical record reviewers will be blinded to randomization arms. The secondary endpoint is an evaluation of the implementation and usability of the text message intervention as a strategy to improve screening adherence. Discussion This intervention using mobile technology intends to raise cervical cancer screening adherence and compliance among a Chilean population of low and middle-low socioeconomic status. If successful, this strategy may reduce the incidence of cervical cancer. Trial registration Clinicaltrials.gov NCT02376023 Registered 2/17/2015. First participant enrolled Feb 22nd 2016.Abstract Background In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized controlled trials in Latin America assessing its use in cervical cancer screening. The ‘Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile’ study aims to determine the efficacy of a text-message intervention on Pap test adherence among Chilean women in the metropolitan region of Santiago. Methods/design This study is a parallel randomized-controlled trial of 400 Chilean women aged 25–64 who are non-adherent with current recommendations for Pap test screening. Participants will be randomly assigned to (1) a control arm (usual care) or (2) an intervention arm, where text and voice messages containing information and encouragement to undergo screening will be sent to the women. The primary endpoint is completion of a Pap test within 6 months of baseline assessment, as determined by medical record review at community-based clinics. Medical record reviewers will be blinded to randomization arms. The secondary endpoint is an evaluation of the implementation and usability of the text message intervention as a strategy to improve screening adherence. Discussion This intervention using mobile technology intends to raise cervical cancer screening adherence and compliance among a Chilean population of low and middle-low socioeconomic status. If successful, this strategy may reduce the incidence of cervical cancer. Trial registration Clinicaltrials.gov NCT02376023 Registered 2/17/2015. First participant enrolled Feb 22nd 2016.Abstract Background In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized controlled trials in Latin America assessing its use in cervical cancer screening. The ‘Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile’ study aims to determine the efficacy of a text-message intervention on Pap test adherence among Chilean women in the metropolitan region of Santiago. Methods/design This study is a parallel randomized-controlled trial of 400 Chilean women aged 25–64 who are non-adherent with current recommendations for Pap test screening. Participants will be randomly assigned to (1) a control arm (usual care) or (2) an intervention arm, where text and voice messages containing information and encouragement to undergo screening will be sent to the women. The primary endpoint is completion of a Pap test within 6 months of baseline assessment, as determined by medical record review at community-based clinics. Medical record reviewers will be blinded to randomization arms. The secondary endpoint is an evaluation of the implementation and usability of the text message intervention as a strategy to improve screening adherence. Discussion This intervention using mobile technology intends to raise cervical cancer screening adherence and compliance among a Chilean population of low and middle-low socioeconomic status. If successful, this strategy may reduce the incidence of cervical cancer. Trial registration Clinicaltrials.gov NCT02376023 Registered 2/17/2015. First participant enrolled Feb 22nd 2016.
- ItemDiplomado de salud y humanización : el valor de la reflexión y el aprendizaje presencial(2015) Martínez Gutiérrez, Javiera; Magliozzi, Pietro; Torres, Patricio; Soto Subiabre, Mauricio Andrés; Walker C., Rosa
- ItemExamining barriers for mammography screening compliance within a private hospital and an underserved primary care clinic in Santiago, Chile(2013) Wood, Mary F.; Vial Alliende, Maria Catalina; Martínez Gutiérrez, Javiera; Mason, Mary J.; Puschel Illanes, Klaus
- ItemIndoor environmental risk factors for pediatric respiratory diseases in an underserved community in Santiago, Chile(2014) Matus Casanova, María Soledad; Sanchez Barja, Trinidad de Las Mercedes; Martínez Gutiérrez, Javiera; Cerda, Jaime; Molina Milman, Helia; Valenzuela Contreras, Patricia
- ItemMessages for your health : mobile use and cancer prevention for underserved Latinas in Santiago, Chile(2016) Martínez Gutiérrez, Javiera; Soto Subiabre, Mauricio Andrés; Momany, Mckenzie; Ciampi, Francis; Capurro, Daniel; Cea, Emilia; Puschel Illanes, Klaus
- ItemMulti-level Intervention to increase participation in mammography screening: ¡Fortaleza Latina! study design(2014) Coronado, G.; Jimenez R.; Martínez Gutiérrez, Javiera; Mclerran, D.; Ornelas, I.; Patrick, D.; Gutierrez, R.; Bishop, S.; Beresford, S.
- ItemOptimising a clinical decision support tool to improve chronic kidney disease management in general practice(2024) Hunter, Barbara; Davidson, Sandra; Lumsden, Natalie; Chima, Sophie; Martínez Gutiérrez, Javiera; Emery, Jon; Nelson, Craig; Manski-Nankervis, Jo-AnneEarly identification and treatment of chronic disease is associated with better clinical outcomes, lower costs, and reduced hospitalisation. Primary care is ideally placed to identify patients at risk of, or in the early stages of, chronic disease and to implement prevention and early intervention measures. This paper evaluates the implementation of a technological intervention called Future Health Today that integrates with general practice EMRs to (1) identify patients at-risk of, or with undiagnosed or untreated, chronic kidney disease (CKD), and (2) provide guideline concordant recommendations for patient care. The evaluation aimed to identify the barriers and facilitators to successful implementation. Methods Future Health Today was implemented in 12 general practices in Victoria, Australia. Fifty-two interviews with 30 practice staff were undertaken between July 2020 and April 2021. Practice characteristics were collected directly from practices via survey. Data were analysed using inductive and deductive qualitative analysis strategies, using Clinical Performance - Feedback Intervention Theory (CP-FIT) for theoretical guidance. Results Future Health Today was acceptable, user friendly and useful to general practice staff, and supported clinical performance improvement in the identification and management of chronic kidney disease. CP-FIT variables supporting use of FHT included the simplicity of design and delivery of actionable feedback via FHT, good fit within existing workflow, strong engagement with practices and positive attitudes toward FHT. Context variables provided the main barriers to use and were largely situated in the external context of practices (including pressures arising from the COVID-19 pandemic) and technical glitches impacting installation and early use. Participants primarily utilised the point of care prompt rather than the patient management dashboard due to its continued presence, and immediacy and relevance of the recommendations on the prompt, suggesting mechanisms of compatibility, complexity, actionability and credibility influenced use. Most practices continued using FHT after the evaluation phase was complete. Conclusions This study demonstrates that FHT is a useful and acceptable software platform that provides direct support to general practice in identifying and managing patients with CKD. Further research is underway to explore the effectiveness of FHT, and to expand the conditions on the platform.
- ItemPlans to obtain a mammogram among Chilean women : the roles of recommendations and self-efficacy(2013) Molina, Y.; Martínez Gutiérrez, Javiera; Thompson, B.
- ItemPreferences of Underserved Chilean Women on a Mobile Technology Intervention for Cervical Cancer Screening : Qualitative Study(2018) Soto Subiabre, Mauricio Andrés; Martínez Gutiérrez, Javiera; Momany, McKenzie; Capurro, Daniel; Ciampi Spode, Francis; Cea, Emilia; Mergudich, Tania; Puschel Illanes, Klaus
- ItemResilience Among Patients Across the Cancer Continuum : Diverse Perspectives(2014) Molina, Y.; Yi, J.; Martínez Gutiérrez, Javiera; Reding, K.; Yi-Frazier, J.; Rosenberg, A.
- ItemResults of a Randomized Controlled Trial to Increase Cervical Cancer Screening Among Rural Latinas(2017) Thompson, Beti; Carosso, Elizabeth A.; Jhingan, Esther; Wang, Lei; Holte, Sarah E.; Byrd, Theresa L.; Benavides, María C.; López, Cathy; Martínez Gutiérrez, Javiera; Ibarra, Genóveva; González, Virginia J.; González, Nora E.; Duggan, Catherine R.
- ItemScreening for autism in Santiago Chile : community perspectives(2015) Eugenin, María I.; Moore Valdés, María Rosario; Martínez Gutiérrez, Javiera; Pérez, Carolina A.; Valenzuela Contreras, Patricia
- ItemSkin prick test of immediate hipersensitivity in a selected Chilean pediatric population sample(SOC MEDICA SANTIAGO, 2005) Martínez Gutiérrez, Javiera; Méndez Rivera, Cecilia del Pilar; Talesnik Guendelman, Eduardo; Campos R., Eugenia; Viviani García, Paola; Sánchez Díaz, Ignacio
- ItemThe SMARTscreen Trial : a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program(2022) Wood, Anna; Emery, Jon D.; Jenkins, Mark; Chondros, Patty; Campbell, Tina; Wenkart, Edweana; O’Reilly, Clare; Cowie, Tony; Dixon, Ian; Martínez Gutiérrez, JavieraBackground: Increasing participation in the Australian National Bowel Cancer Screening Program (NBCSP) is the most efficient and cost-effective way of reducing mortality associated with colorectal cancer by detecting and treating early-stage disease. Currently, only 44% of Australians aged 50–74 years complete the NBCSP. This efficacy trial aims to test whether this SMS intervention is an effective method for increasing participation in the NBCSP. Furthermore, a process evaluation will explore the barriers and facilitators to sending the SMS from general practice. Methods: We will recruit 20 general practices in the western region of Victoria, Australia to participate in a cluster randomised controlled trial. General practices will be randomly allocated with a 1:1 ratio to either a control or intervention group. Established general practice software will be used to identify patients aged 50 to 60 years old who are due to receive a NBCSP kit in the next month. The SMS intervention includes GP endorsement and links to narrative messages about the benefits of and instructions on how to complete the NBCSP kit. It will be sent from intervention general practices to eligible patients prior to receiving the NBCSP kit. We require 1400 eligible patients to provide 80% power with a two-sided 5% significance level to detect a 10% increase in CRC screening participation in the intervention group compared to the control group. Our primary outcome is the difference in the proportion of eligible patients who completed a faecal occult blood test (FOBT) between the intervention and control group for up to 12 months after the SMS was sent, as recorded in their electronic medical record (EMR). A process evaluation using interview data collected from general practice staff (GP, practice managers, nurses) and patients will explore the feasibility and acceptability of sending and receiving a SMS to prompt completing a NBCSP kit. Discussion: This efficacy trial will provide initial trial evidence of the utility of an SMS narrative intervention to increase participation in the NBCSP. The results will inform decisions about the need for and design of a larger, multi-state trial of this SMS intervention to determine its cost-effectiveness and future implementation.
- ItemToward Patient-Centered Care : Understanding Latina Patients’ Perceptions of Screening Mammographys(2016) Martínez Gutiérrez, Javiera; Jhingan, E.; Black, L. E.; Hayes, Constant T.; Coronado, G. D.